91 related articles for article (PubMed ID: 28059514)
1. Myelography Iodinated Contrast Media. 2. Conformational Versatility of Iopamidol in the Solid State.
Bellich B; Di Fonzo S; Tavagnacco L; Paolantoni M; Masciovecchio C; Bertolotti F; Giannini G; De Zorzi R; Geremia S; Maiocchi A; Uggeri F; Masciocchi N; Cesàro A
Mol Pharm; 2017 Feb; 14(2):468-477. PubMed ID: 28059514
[TBL] [Abstract][Full Text] [Related]
2. Myelography iodinated contrast media. I. Unraveling the atropisomerism properties in solution.
Fontanive L; D'Amelio N; Cesàro A; Gamini A; Tavagnacco L; Paolantoni M; Brady JW; Maiocchi A; Uggeri F
Mol Pharm; 2015 Jun; 12(6):1939-50. PubMed ID: 25945970
[TBL] [Abstract][Full Text] [Related]
3. Involvement of protein solvation in the interaction between a contrast medium (iopamidol) and fibrinogen or lysozyme.
Brass O; Letoffé JM; Bakkali A; Bureau JC; Corot C; Claudy P
Biophys Chem; 1995 Mar; 54(1):83-94. PubMed ID: 7703352
[TBL] [Abstract][Full Text] [Related]
4. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of polymorphism and solvation in tranilast.
Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
[TBL] [Abstract][Full Text] [Related]
6. Theoretical B3LYP Study on Electronic Structure of Contrast Agent Iopamidol.
Genç F; Kandemirli SG; Kandemirli F
Acta Chim Slov; 2021 Jun; 68(2):320-331. PubMed ID: 34738120
[TBL] [Abstract][Full Text] [Related]
7. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
8. Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study.
Heinz A; Gordon KC; McGoverin CM; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2009 Jan; 71(1):100-8. PubMed ID: 18590814
[TBL] [Abstract][Full Text] [Related]
9. Borate complexes of x-ray iodinated contrast agents: characterization and sorption studies for their removal from aqueous media.
Rustighi I; Donati I; Ferluga M; Campa C; Pasqua AE; Rossi M; Paoletti S
J Hazard Mater; 2012 Feb; 205-206():10-6. PubMed ID: 22245510
[TBL] [Abstract][Full Text] [Related]
10. Isomeric purity and supersaturation of iopamidol.
Dawson P; Pitfield J; Skinnemoen K
Br J Radiol; 1983 Oct; 56(670):711-3. PubMed ID: 6616135
[TBL] [Abstract][Full Text] [Related]
11. The spectroscopic (FT-IR, FT-Raman, dispersive Raman and NMR) study of ethyl-6-chloronicotinate molecule by combined density functional theory.
Karabacak M; Calisir Z; Kurt M; Kose E; Atac A
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 153():754-70. PubMed ID: 26483317
[TBL] [Abstract][Full Text] [Related]
12. Conformational polymorphs of isobutyl-6-amino-5-cyano-2-methyl-4-phenyl-4H-pyran-3-carboxylate: spectroscopic, structural and DFT approach.
Prasad AA; Kumar CU; Prakasam BA; Meenakshisundaram SP
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Jun; 72(Pt 3):301-9. PubMed ID: 27240761
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopy.
Hu Y; Wikström H; Byrn SR; Taylor LS
J Pharm Biomed Anal; 2007 Nov; 45(4):546-51. PubMed ID: 17851013
[TBL] [Abstract][Full Text] [Related]
14. Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Wang JR; Li S; Zhu B; Mei X
J Pharm Biomed Anal; 2015 May; 109():45-51. PubMed ID: 25746505
[TBL] [Abstract][Full Text] [Related]
15. [1st experience with Solutrast, a new contrast medium for myelography].
Thun F
Rontgenblatter; 1983 Jan; 36(1):6-9. PubMed ID: 6823535
[TBL] [Abstract][Full Text] [Related]
16. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
[TBL] [Abstract][Full Text] [Related]
17. Phase transformation in conformational polymorphs of nimesulide.
Sanphui P; Sarma B; Nangia A
J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
[TBL] [Abstract][Full Text] [Related]
18. Polymorph screening of an active material.
Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic (FT-IR, FT-Raman, UV and NMR) investigation on 1-phenyl-2-nitropropene by quantum computational calculations.
Xavier S; Periandy S
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():216-30. PubMed ID: 25965169
[TBL] [Abstract][Full Text] [Related]
20. Properties of iopamidol-incorporated poly(vinyl alcohol) microparticle as an X-ray imaging flow tracer.
Ahn S; Jung SY; Lee JP; Lee SJ
J Phys Chem B; 2011 Feb; 115(5):889-901. PubMed ID: 21222463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
